During the past decade, WVUH-Berkely Medical Center conducted 49 clinical trials. In the 10-year time frame, 49 clinical trials started and 14 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 14 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "WVUH-Berkely Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 24 trials, followed by "SWOG Cancer Research Network" with 12 trials sponsored, "Alliance for Clinical Trials in Oncology" with 9 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored and "NRG Oncology" with 6 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "WVUH-Berkely Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 31 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "WVUH-Berkely Medical Center" are "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials), "Invasive Breast Carcinoma" (3 trials), "Stage IIA Breast Cancer" (3 trials) and "Stage IIB Breast Cancer" (3 trials). Many other conditions were trialed in "WVUH-Berkely Medical Center" in a lesser frequency.

Most popular intervention types in "WVUH-Berkely Medical Center" are "Other" (44 trials), "Drug" (41 trials), "Biological" (27 trials), "Procedure" (19 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (23 trials), "Quality-of-Life Assessment" (19 trials), "Computed Tomography" (11 trials), "Nivolumab" (11 trials) and "Questionnaire Administration" (11 trials). Other intervention names were less common.

The vast majority of trials in "WVUH-Berkely Medical Center" are 49 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "WVUH-Berkely Medical Center". undefined are not yet recruiting, 19 are recruiting, 25 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in WVUH-Berkely Medical Center, 2 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in WVUH-Berkely Medical Center, 1 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".